BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37520825)

  • 1. Auto-immunoproteomics analysis of COVID-19 ICU patients revealed increased levels of autoantibodies related to the male reproductive system.
    Schmidt F; Abdesselem HB; Suhre K; Vaikath NN; Sohail MU; Al-Nesf M; Bensmail I; Mashod F; Sarwath H; Bernhardt J; Schaefer-Ramadan S; Tan TM; Morris PE; Schenck EJ; Price D; Mohamed-Ali V; Al-Maadheed M; Arredouani A; Decock J; Blackburn JM; Choi AMK; El-Agnaf OM
    Front Physiol; 2023; 14():1203723. PubMed ID: 37520825
    [No Abstract]   [Full Text] [Related]  

  • 2. High-throughput autoantibody screening identifies differentially abundant autoantibodies in autism spectrum disorder.
    Mesleh A; Ehtewish H; Lennard K; Abdesselem HB; Al-Shaban F; Decock J; Alajez NM; Arredouani A; Emara MM; Albagha O; Stanton LW; Abdulla SA; Blackburnand JM; El-Agnaf OMA
    Front Mol Neurosci; 2023; 16():1222506. PubMed ID: 37908488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with severe COVID-19 do not have elevated autoantibodies against common diagnostic autoantigens.
    Ulndreaj A; Wang M; Misaghian S; Paone L; Sigal GB; Stengelin M; Campbell C; Van Nynatten LR; Soosaipillai A; Ghorbani A; Mathew A; Fraser DD; Diamandis EP; Prassas I
    Clin Chem Lab Med; 2022 Jun; 60(7):1116-1123. PubMed ID: 35475723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Antibody Against SNRPB, Small Nuclear Ribonucleoprotein-Associated Proteins B and B', as an Autoantibody Marker in Crohn's Disease using an Immunoproteomics Approach.
    Wang H; Demirkan G; Bian X; Wallstrom G; Barker K; Karthikeyan K; Tang Y; Pasha SF; Leighton JA; Qiu J; LaBaer J
    J Crohns Colitis; 2017 Jul; 11(7):848-856. PubMed ID: 28204086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantigen Microarray for High-throughput Autoantibody Profiling in Systemic Lupus Erythematosus.
    Zhu H; Luo H; Yan M; Zuo X; Li QZ
    Genomics Proteomics Bioinformatics; 2015 Aug; 13(4):210-8. PubMed ID: 26415621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoproteomics approach revealed elevated autoantibody levels against ANXA1 in early stage gallbladder carcinoma.
    Akhtar J; Priya R; Jain V; Sakhuja P; Agarwal AK; Goyal S; Polisetty RV; Sirdeshmukh R; Kar S; Gautam P
    BMC Cancer; 2020 Dec; 20(1):1175. PubMed ID: 33261560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to ACE2 and immune molecules are associated with COVID-19 disease severity.
    Geanes ES; McLennan R; LeMaster C; Bradley T
    Commun Med (Lond); 2024 Mar; 4(1):47. PubMed ID: 38491326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity.
    Baiocchi GC; Vojdani A; Rosenberg AZ; Vojdani E; Halpert G; Ostrinski Y; Zyskind I; Filgueiras IS; Schimke LF; Marques AHC; Giil LM; Lavi YB; Silverberg JI; Zimmerman J; Hill DA; Thornton A; Kim M; De Vito R; Fonseca DLM; Plaça DR; Freire PP; Camara NOS; Calich VLG; Scheibenbogen C; Heidecke H; Lattin MT; Ochs HD; Riemekasten G; Amital H; Shoenfeld Y; Cabral-Marques O
    J Med Virol; 2023 Feb; 95(2):e28538. PubMed ID: 36722456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of autoantigens and their potential post-translational modification in EGPA and severe eosinophilic asthma.
    Esposito I; Kontra I; Giacomassi C; Manou-Stathopoulou S; Brown J; Stratton R; Verykokou G; Buccafusca R; Stevens M; Nissim A; Lewis MJ; Pfeffer PE
    Front Immunol; 2023; 14():1164941. PubMed ID: 37334358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse Functional Autoantibodies in Patients with COVID-19.
    Wang EY; Mao T; Klein J; Dai Y; Huck JD; Liu F; Zheng NS; Zhou T; Israelow B; Wong P; Lucas C; Silva J; Oh JE; Song E; Perotti ES; Fischer S; Campbell M; Fournier JB; Wyllie AL; Vogels CBF; Ott IM; Kalinich CC; Petrone ME; Watkins AE; ; Cruz CD; Farhadian SF; Schulz WL; Grubaugh ND; Ko AI; Iwasaki A; Ring AM
    medRxiv; 2021 Feb; ():. PubMed ID: 33330894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 is associated with bystander polyclonal autoreactive B cell activation as reflected by a broad autoantibody production, but none is linked to disease severity.
    Jiang W; Johnson D; Adekunle R; Heather H; Xu W; Cong X; Wu X; Fan H; Andersson LM; Robertson J; Gisslén M
    J Med Virol; 2023 Jan; 95(1):e28134. PubMed ID: 36086941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantigen microarrays reveal autoantibodies associated with proliferative nephritis and active disease in pediatric systemic lupus erythematosus.
    Haddon DJ; Diep VK; Price JV; Limb C; Utz PJ; Balboni I
    Arthritis Res Ther; 2015 Jun; 17(1):162. PubMed ID: 26081107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of IgG4 Anti-Gliadin Autoantibody as a Potential Biomarker of Psoriasis Using an Autoantigen Array.
    Qiu J; Yuan Y; Li Y; Haley C; Mui UN; Swali R; Mohan C; Tyring SK; Wu T
    Proteomics Clin Appl; 2020 Mar; 14(2):e1800114. PubMed ID: 31671471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19).
    Lerma LA; Chaudhary A; Bryan A; Morishima C; Wener MH; Fink SL
    J Transl Autoimmun; 2020; 3():100073. PubMed ID: 33263103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverse functional autoantibodies in patients with COVID-19.
    Wang EY; Mao T; Klein J; Dai Y; Huck JD; Jaycox JR; Liu F; Zhou T; Israelow B; Wong P; Coppi A; Lucas C; Silva J; Oh JE; Song E; Perotti ES; Zheng NS; Fischer S; Campbell M; Fournier JB; Wyllie AL; Vogels CBF; Ott IM; Kalinich CC; Petrone ME; Watkins AE; ; Dela Cruz C; Farhadian SF; Schulz WL; Ma S; Grubaugh ND; Ko AI; Iwasaki A; Ring AM
    Nature; 2021 Jul; 595(7866):283-288. PubMed ID: 34010947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibody profile in sarcoidosis, analysis from the GRADS sarcoidosis cohort.
    Khassawneh B; Zhu C; Barkes B; Vestal B; Shrock S; Gillespie M; Pacheco K; Deane KD; Maier LA; Li QZ; Hamzeh N;
    PLoS One; 2022; 17(10):e0274381. PubMed ID: 36264970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies targeting TLR and SMAD pathways define new subgroups in systemic lupus erythematosus.
    Lewis MJ; McAndrew MB; Wheeler C; Workman N; Agashe P; Koopmann J; Uddin E; Morris DL; Zou L; Stark R; Anson J; Cope AP; Vyse TJ
    J Autoimmun; 2018 Jul; 91():1-12. PubMed ID: 29576246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes.
    Li QZ; Zhou J; Wandstrat AE; Carr-Johnson F; Branch V; Karp DR; Mohan C; Wakeland EK; Olsen NJ
    Clin Exp Immunol; 2007 Jan; 147(1):60-70. PubMed ID: 17177964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies in COVID-19 correlate with antiviral humoral responses and distinct immune signatures.
    Taeschler P; Cervia C; Zurbuchen Y; Hasler S; Pou C; Tan Z; Adamo S; Raeber ME; Bächli E; Rudiger A; Stüssi-Helbling M; Huber LC; Brodin P; Nilsson J; Probst-Müller E; Boyman O
    Allergy; 2022 Aug; 77(8):2415-2430. PubMed ID: 35364615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibody discovery across monogenic, acquired, and COVID-19-associated autoimmunity with scalable PhIP-seq.
    Vazquez SE; Mann SA; Bodansky A; Kung AF; Quandt Z; Ferré EMN; Landegren N; Eriksson D; Bastard P; Zhang SY; Liu J; Mitchell A; Proekt I; Yu D; Mandel-Brehm C; Wang CY; Miao B; Sowa G; Zorn K; Chan AY; Tagi VM; Shimizu C; Tremoulet A; Lynch K; Wilson MR; Kämpe O; Dobbs K; Delmonte OM; Bacchetta R; Notarangelo LD; Burns JC; Casanova JL; Lionakis MS; Torgerson TR; Anderson MS; DeRisi JL
    Elife; 2022 Oct; 11():. PubMed ID: 36300623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.